Mutational status of PIK3ca oncogene in oral cancer—In the new age of PI3K inhibitors
Author:
V. Denninghoff,A. Muino,M. Diaz,L. Harada,A. Lence,P. Turon,M. Labbrozzi,S. Aguas,P. Peñaloza,A. Avagnina,I. Adler
Publication:
Pathology - Research and Practice
© 2019 Elsevier GmbH. All rights reserved.